Showing results (311-320 of 736) with videos related to
Sort By:
Pageof 74
British Journal of Anaesthesia|September 1, 1988
Propofol reduces seizure duration in patients having anaesthesia for electroconvulsive therapyK H Simpson, P J Halsall, C M Carr, et al.Pharmacotherapy|September 12, 2002
Development and validation of a survey to assess barriers to drug use in patients with chronic heart failureScot H Simpson, Jeffrey A Johnson, Karen B Farris, et al.Pharmacotherapy|March 26, 2004
Greater effect of enhanced pharmacist care on cholesterol management in patients with diabetes mellitus: a planned subgroup analysis of the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP)Scot H Simpson, Jeffrey A Johnson, Rosemarie S Biggs, et al.Pharmacotherapy|June 2, 2005
Secondary failure rates associated with metformin and sulfonylurea therapy for type 2 diabetes mellitusDean T Eurich, Scot H Simpson, Sumit R Majumdar, et al.The Journal of Bone and Joint Surgery. British Volume|July 1, 1994
Proprioception enhancement for anterior cruciate ligament deficiency. A prospective randomised trial of two physiotherapy regimesD J Beard, C A Dodd, H R Trundle, et al.BMJ Open|October 29, 2025
Rurality, type 2 diabetes and risk of cardiovascular events in Alberta, Canada: a retrospective cohort studyDanielle K Nagy, Lauren C Bresee, Dean T Eurich, et al.Journal of Primary Health Care|December 22, 2020
Monitoring the use of dabigatran etexilate for stroke prevention: compliance with renal function guidelinesBryan H Simpson, David M Reith, Natalie J Medlicott, et al.Journal of the Royal Society of Medicine|December 1, 1985
Sleep apnoea in infancyF A Abreu e Silva, U M MacFadyen, A Williams, et al.Canadian Journal of Diabetes|April 7, 2024
Are Guideline-concordant Processes of Care Consistent Across the Rural-Urban Continuum? A Retrospective Cohort Study of Adults Newly Treated for Type 2 DiabetesDanielle K Nagy, Lauren C Bresee, Dean T Eurich, et al.Exploratory Research in Clinical and Social Pharmacy|March 18, 2024
Rurality is associated with lower likelihood of dipeptidyl peptidase 4 inhibitor use for treatment intensificationDanielle K Nagy, Lauren C Bresee, Dean T Eurich, et al.Pageof 74